Read More Pharma Industry News American Regent’s HEART-FID trial for INJECTAFER fails to meet primary endpoint American Regent, Inc., a subsidiary of Daiichi Sankyo Group, has announced disappointing results from its phase 3 HEART-FID… byPallavi MadhirajuAugust 27, 2023